TFA Therapeutics (RAJAF) Preferred Stock Liabilities (2021)
TFA Therapeutics (RAJAF) posted Preferred Stock Liabilities of $222400.0 for Q4 2021.
Powered by 
Analysis
TFA Therapeutics (RAJAF) Preferred Stock Liabilities (2021) Analysis & Trends
TFA Therapeutics has reported Preferred Stock Liabilities for 1 years, with the latest figure at $222400.0 in Q4 2021.
- On a quarterly basis, Preferred Stock Liabilities changed N/A year-over-year to $222400.0 in Q4 2021; TTM through Dec 2021 was $222400.0, a N/A change from a year earlier, with the FY2021 full-year figure at $222400.0, changed N/A from the prior year.
- Preferred Stock Liabilities was $222400.0 for Q4 2021 at TFA Therapeutics.
- The five-year high for Preferred Stock Liabilities was $222400.0 in Q4 2021, with the low at $222400.0 in Q4 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Colgate Palmolive | 70.44 Bn | 69.07 Bn | 3.30 Bn | - |
| 2 | Kenvue | 34.45 Bn | 33.34 Bn | 2.30 Bn | - |
| 3 | Kimberly Clark | 33.15 Bn | 32.20 Bn | 1.60 Bn | - |
| 4 | Bath & Body Works | 3.98 Bn | 3.19 Bn | 692.00 Mn | - |
| 5 | Prestige Consumer Healthcare | 2.37 Bn | 2.30 Bn | - | - |
| 6 | Perrigo | 2.01 Bn | 1.61 Bn | 313.90 Mn | - |
| 7 | Herbalife | 1.27 Bn | 903.35 Mn | 1.03 Bn | - |
| 8 | Edgewell Personal Care | 1.26 Bn | 864.66 Mn | 242.50 Mn | - |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - | - |
| 10 | Honest Company | 614.48 Mn | 508.58 Mn | 40.36 Mn | - |